Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 20, 10 Issues, 2021
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

Meet the Executive Guest Editor(s)

P. Chawla
ISF College of Pharmacy
Moga
(India)
Dr Pooja Chawla is working as a Professor and the head at the Department of Pharmaceutical Analysis, ISF College of Pharmacy Moga, India. She has nearly 13 years of experience in the research, discovery and development of biologically active pharmaceuticals. Dr Chawla holds a PhD degree in Medicinal Chemistry and has published 3 books and more than 40 papers in national/international journals. She is currently serving as a reviewer for international journals of repute. She also presented a poster at FIP in 2011 and CTDDR in 2013 and delivered an oral talk at the World Chemistry Congress, Dubai 2019. She has guided 47 post-graduate projects, and her research team involves 3 master and 2 doctoral research scholars.


Malvina Hoxha
Catholic University Our Lady of Good Counsel
Tirana
(Albania)
Dr. Hoxha is a researcher and lecturer of pharmacology at the Catholic University ‘Our Lady of Good Counsel’, Tirana, Albania. She graduated in pharmacy (Summa cum Laude), and obtained her PhD in pharmacology at the Department of Pharmacological and Biomolecular Sciences, University of Milan. Her area of research is focused mainly on arachidonic acid metabolites and their role in different in- flammatory diseases. Dr. Hoxha attended a post-doctorate at the University of Granada, Spain, and recently she obtained a research award from the Austrian Academy of Science. In 2019, she was elected as a national delegate of the ERS (European Respiratory Society).


Aristeidis H. Katsanos
McMaster University
Hamilton, ON
(Canada)
Dr. Aristeidis H. Katsanos, MD, Ph.D., is currently a clinical fellow in stroke medicine at the McMaster University, Hamilton, Ontario, Canada. He received his graduate and post-graduate degrees from the University of Ioannina School of Medicine, Greece. His research focuses on the evidence-based evaluation of emerging diagnostic and therapeutic approaches to acute stroke treatment and secondary stroke prevention. He has a particular enthusiasm for epidemiology, biostatistics and meta-research. He has actively participated in numerous research projects and international collaborations and has published more than 140 papers in high-impact medical journals, indexed in PubMed, which according to Google Scholar, have received more than 1981 cita- tions (H-index 26), to date.


R. Kumar
Ravenshaw University
Cuttack
(India)
Dr. Rituraj Niranjan is currently working as a Scientist-C in the area of immune system associated disorders. He is engaged in the different immune system associated disorders like, allergy, fibrosis, acute kidney failure, neuroinflammation, nanoparticle-based drug delivery system. Dr. Rituraj Niranjan work focuses on the role of Interleukin-15 (IL-15) in the gastrointestinal disorders. He has done his Ph.D. degree from Jawaharlal Nehru University, New Delhi in the area of neuropharmacology working at the central drug Research institute (CDRI), Lucknow, India. He completed his first post doc from the University of Arkansas for Medical Sciences, Little Rock, USA and then did his second post doc from Cincinnati Children Hospital and Medical Research Centre, Cincinnati, Ohio, USA.


Hari S. Sharma
Uppsala University
Uppsala
(Sweden)
Dr. Hari Shanker Sharma obtained his PhD in 1982 from Banaras Hindu University and Dr Med Sci in 1999 from Uppsala University and engaged in Neuroscience research over 40 years. He is currently the Director of Research International Experimental CNS Injury & Repair (IECNSIR) based at Uppsala University. He authored more than 250 original research papers and Edited several Books in Progress in Brain Research Series and International Review of Neurobiology series. His current research includes Nano delivery of drugs to treat CNS injury and enhance neurorepair.


D. Stoyanov
Medical University of Plovdiv
Plovdiv
(Bulgaria)
Dr. Drozdstoy Stoyanov holds currently the academic position of Full Professor and Head of the Department of Psychiatry and Medical Psychology and Scientific Secretary of the Research Institute at Medical University, Plovdiv. He is Vice Chair of Philosophy SIG, Royal College of Psychiatrists, UK, Visiting Fellow in the University of Pittsburgh, USA (2009), International Distinguished Fellow of the American Psychiatric Association (2018), Guest Lecturer in the Universities of Copenhagen (2015), Vienna (2017) and Bergen (2018).He published more than 180 scholarly papers, including five monographs and three textbooks. Dr. Stoyanov is Associate Editor of Frontiers in Psychiatry and the European Journal of Person Centered Health Care; Editorial Board member of Current Topics in Medicinal Chemistry, Dialogues in Philosophy, Mental and Neurosciences, International Journal for Person Centered Medicine, and others. Ad hoc reviewer in Molecular Neurobiology, Human Brain Mapping, Journal of Affective Disorders, The World Journal of Biological Psychiatry, Journal of Evaluation in Clinical Practice, Biotechnology and Biotechnological Equipment.


K. Xiong
Central South University
Changsha
(China)
Prof. Kun Xiong is the Chairman of the Department of Anatomy & Neurobiology at the School of Basic Medical Science, Central South University. His research interests include the regulatory mechanisms of neuronal death, including apoptosis and necroptosis in brain disorders and glaucoma. Prof. Kun Xiong earned his Bachelor of Medicine (Clinical Medicine) and PhD degrees in human anatomy at Central South University. He has worked as a visiting scholar at the Department of Anatomy in the School of Medicine, Southern Illinois University, US. Notably, Prof. Kun Xiong’s research has been funded by more than 10 foundations, including 4 National Natural Science Foundations of China. He has authored 60 manuscripts. He has also served as a reviewer for multiple international journals and as an editorial member for several journals (Medicine and Neural Regeneration Research, etc.).


H. Zhang
Shanghai University of Traditional Chinese Medicine
Shanghai
(China)
Dr. Hong Zhang received his PhD degree in Formulaology from Chengdu University of Traditional Chinese Medicine in 2005. He joined the Second Military Medical University as a Lecturer in 2005 and became an Associate Professor in 2009. He worked as a specially invited research fellow for Shanghai Seventh People’s Hospital from 2014 to 2018. He moved to Shanghai University of Traditional Chinese Medicine as an Associate Professor in 2018. Dr Zhang has undertaken more than 25 projects, applied for 15 patents, and published 9 books and more than 140 articles. His research interests are focused on the activity screening, target and compatibility mechanism for Chinese medicines and natural products.


Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 6.8

Related Journals

Related eBooks

eBooks Catalog